165 related articles for article (PubMed ID: 36313392)
21. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles.
Bouchentouf M; Benabdallah BF; Bigey P; Yau TM; Scherman D; Tremblay JP
Gene Ther; 2008 Mar; 15(6):404-14. PubMed ID: 18079754
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs.
Parker MH; Kuhr C; Tapscott SJ; Storb R
Mol Ther; 2008 Jul; 16(7):1340-6. PubMed ID: 18500253
[TBL] [Abstract][Full Text] [Related]
23. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
24. Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice.
Sun C; Choi IY; Rovira Gonzalez YI; Andersen P; Talbot CC; Iyer SR; Lovering RM; Wagner KR; Lee G
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32343677
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effects of mouse adipose-derived stem cells and losartan in the skeletal muscle of injured mdx mice.
Lee EM; Kim AY; Lee EJ; Park JK; Lee MM; Hwang M; Kim CY; Kim SY; Jeong KS
Cell Transplant; 2015; 24(5):939-53. PubMed ID: 24593934
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs.
Dell'Agnola C; Wang Z; Storb R; Tapscott SJ; Kuhr CS; Hauschka SD; Lee RS; Sale GE; Zellmer E; Gisburne S; Bogan J; Kornegay JN; Cooper BJ; Gooley TA; Little MT
Blood; 2004 Dec; 104(13):4311-8. PubMed ID: 15328150
[TBL] [Abstract][Full Text] [Related]
27. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
[TBL] [Abstract][Full Text] [Related]
28. Effects of omega-3 on matrix metalloproteinase-9, myoblast transplantation and satellite cell activation in dystrophin-deficient muscle fibers.
de Carvalho SC; Hindi SM; Kumar A; Marques MJ
Cell Tissue Res; 2017 Sep; 369(3):591-602. PubMed ID: 28623422
[TBL] [Abstract][Full Text] [Related]
29. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
[TBL] [Abstract][Full Text] [Related]
30. Induced Fetal Human Muscle Stem Cells with High Therapeutic Potential in a Mouse Muscular Dystrophy Model.
Zhao M; Tazumi A; Takayama S; Takenaka-Ninagawa N; Nalbandian M; Nagai M; Nakamura Y; Nakasa M; Watanabe A; Ikeya M; Hotta A; Ito Y; Sato T; Sakurai H
Stem Cell Reports; 2020 Jul; 15(1):80-94. PubMed ID: 32619494
[TBL] [Abstract][Full Text] [Related]
31. Stem cell-based therapies for Duchenne muscular dystrophy.
Sun C; Serra C; Lee G; Wagner KR
Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376
[TBL] [Abstract][Full Text] [Related]
32. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
33. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice.
Mackenzie TC; Shaaban AF; Radu A; Flake AW
J Pediatr Surg; 2002 Jul; 37(7):1058-64. PubMed ID: 12077771
[TBL] [Abstract][Full Text] [Related]
34. Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts.
Gosselin MRF; Mournetas V; Borczyk M; Verma S; Occhipinti A; Róg J; Bozycki L; Korostynski M; Robson SC; Angione C; Pinset C; Gorecki DC
Elife; 2022 Sep; 11():. PubMed ID: 36164827
[TBL] [Abstract][Full Text] [Related]
35. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.
Benabdallah BF; Bouchentouf M; Tremblay JP
Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Muscle Function Following hiPSC-Derived Myoblast Transplantation in Dystrophic Mice.
Fabre P; Molina T; Orfi Z; Dumont NA
Curr Protoc; 2022 Jan; 2(1):e356. PubMed ID: 35085428
[TBL] [Abstract][Full Text] [Related]
37. A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1.
Xu D; Zhao L; Jiang J; Li S; Sun Z; Huang X; Li C; Wang T; Sun L; Li X; Jiang Z; Zhang L
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1306-1320. PubMed ID: 32869445
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of human iPSC-derived muscle stem cells in the diaphragm of Duchenne muscular dystrophy model mice.
Miura Y; Sato M; Kuwahara T; Ebata T; Tabata Y; Sakurai H
PLoS One; 2022; 17(4):e0266391. PubMed ID: 35377913
[TBL] [Abstract][Full Text] [Related]
39. [Cell therapy for Duchenne muscular dystrophy].
Zhou C; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):659-61. PubMed ID: 17160947
[TBL] [Abstract][Full Text] [Related]
40. Exosome-Derived Dystrophin from Allograft Myogenic Progenitors Improves Cardiac Function in Duchenne Muscular Dystrophic Mice.
Su X; Jin Y; Shen Y; Ju C; Cai J; Liu Y; Kim IM; Wang Y; Yu H; Weintraub NL; Jiang M; Tang Y
J Cardiovasc Transl Res; 2018 Oct; 11(5):412-419. PubMed ID: 30155598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
